MedTrace Logo

Patient Reported Health-Related Quality of Life After Limited Access and Conventional Aortic Valve Replacement

NCT04012060 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2021-05-13

No results posted yet for this study

Summary

The LIAR-Trial is a single-center, single blind randomized controlled clinical trial comparing patients undergoing isolated AVR via J-shaped upper hemi-sternotomy (UHS) and conventional AVR through a full median sternotomy (FMS). Primary outcome is cardiac-specific quality of life, measured by two domains of the Kansas City Cardiomyopathy Questionnaire (KCCQ), up to one year after surgery.

Conditions

  • Aortic Valve Stenosis
  • Limited Access Aortic Valve Replacement
  • Quality of Life

Interventions

PROCEDURE

Limited access aortic valve replacement.

Limited access aortic valve replacement through partial upper hemisternotomy

PROCEDURE

Conventional aortic valve replacement

Aortic valve replacement through full median sternotomy

Sponsors & Collaborators

  • St. Antonius Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-13
Primary Completion
2020-07-07
Completion
2020-07-07

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04012060 on ClinicalTrials.gov